Stingray
Payments companies reported to CMS as associated with Stingray. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Stingray, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Stingray
These are the largest totals companies reported as associated with Stingray. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ricardo Santiago | Manati, PR | Interventional Cardiology | $1,255.34 |
| Darshan Doshi | Boston, MA | Interventional Cardiology | $719.13 |
| Kathleen Kearney | Seattle, WA | Interventional Cardiology | $638.23 |
| Anbukarasi Maran | Charleston, SC | Interventional Cardiology | $584.95 |
| Suhail Dohad | Beverly Hills, CA | Interventional Cardiology | $563.26 |
| Arely Hernandez | Chicago, IL | Physician Assistant | $533.52 |
| Samantha Carruthers | Chicago, IL | Physician Assistant | $533.52 |
| Prasad Gunasekaran | Kansas City, KS | Interventional Cardiology | $500.00 |
| Jaikirshan Khatri | New York, NY | Interventional Cardiology | $500.00 |
| Samuel Horr | Nashville, TN | Interventional Cardiology | $500.00 |
Prescribed Stingray?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.